XRS [TAL Education] 6-K: TAL Education Group Announces Unaudited Financial Results for

[TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2018 - Quarterly Results: Net Revenues up by 59.4% Year-Over-Year Income from Operations up by 54.0% Year-Over-Year Non-GAAP Income from Operations up by 47.7% Year-Over-Year Total Student Enr]

By | 2018-04-27T13:00:43+00:00 April 27th, 2018|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac to Delay Filing of 2017 Annual Report

[Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing BEIJING, April 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today ]

By | 2018-04-27T13:07:18+00:00 April 27th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

HSOL [Hanwha Q CELLS] 20-F: (Original Filing)

[] [1. Hanwha SolarOne Investment Holding Ltd. (BVI) 2. Hanwha Q CELLS Corp. (Korea) 3. 4. Hanwha Q CELLS Hong Kong Limited (PRC) 5. Hanwha Q CELLS (Nantong) Co., Ltd. (PRC) 6. Hanwha Q CELLS Canada Corp. (Canada) 7. Hanwha Q CELLS (Qidong) Co., Ltd. (PRC) 8. Hanwha Q CELLS (Shanghai) Co., Ltd. (PRC)]

By | 2018-04-28T02:07:36+00:00 April 27th, 2018|Categories: Chinese Stocks, HSOL, SEC Original|Tags: , , , , , |0 Comments

BITA [BITAUTO] 20-F: (Original Filing)

[] [EXECUTION VERSION YIXIN CAPITAL LIMITED SERIES C PREFERENCE SHARES SUBSCRIPTION AGREEMENT Dated as of May 11, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND TERMS 2 Section 1.1 Definitions 2 Section 1.2 Other Definitional Provisions 9 ARTICLE II PURCHASE AND SALE 10 Section 2.1 Sale and Is]

ZX [China Zenix Auto International] 20-F: (Original Filing)

[PART I 3 Item 1. Identity of Directors, Senior Management and Advisers 3 Item 2. Offer Statistics and Expected Timetable 3 Item 3. Key Information 3 Item 4. Information on the Company 27 Item 4A. Unresolved Staff Comments 52 Item 5. Operating and Financial Review and Prospects 52 Item 6. Directors, ]

By | 2018-04-27T13:01:29+00:00 April 27th, 2018|Categories: Chinese Stocks, SEC Original, ZX|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Enters into Amendment to Amalgamation Agreement for

[Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction Under the terms of the Amalgamation Agreement, the Amalgamation Agreement may be terminated by the Company or Parent if the amalgamation of Amalgamation Sub with and into the Company (the “Amalgamation”) has not oc]

By | 2018-04-27T13:07:25+00:00 April 27th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

HSOL [Hanwha Q CELLS] 20-F:

[] [1. Hanwha SolarOne Investment Holding Ltd. (BVI) 2. Hanwha Q CELLS Corp. (Korea) 3. 4. Hanwha Q CELLS Hong Kong Limited (PRC) 5. Hanwha Q CELLS (Nantong) Co., Ltd. (PRC) 6. Hanwha Q CELLS Canada Corp. (Canada) 7. Hanwha Q CELLS (Qidong) Co., Ltd. (PRC) 8. Hanwha Q CELLS (Shanghai) Co., Ltd. (PRC)]

By | 2018-04-28T02:07:40+00:00 April 27th, 2018|Categories: Chinese Stocks, HSOL, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar